|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
46,320,000 |
Market
Cap: |
1.76(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38 - $38 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2021-02-24 |
4 |
D |
$25.71 |
$130,890 |
D/D |
(5,091) |
80,443 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2021-02-24 |
4 |
D |
$25.71 |
$131,121 |
D/D |
(5,100) |
126,244 |
|
- |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2020-12-11 |
4 |
D |
$16.14 |
$186,950 |
D/D |
(11,583) |
85,534 |
|
- |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2020-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
97,117 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2020-12-11 |
4 |
D |
$16.14 |
$186,950 |
D/D |
(11,583) |
126,427 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2020-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
138,010 |
|
- |
|
Smith David V |
Executive Vice President & CFO |
|
2020-12-11 |
4 |
D |
$16.14 |
$185,675 |
D/D |
(11,504) |
78,057 |
|
- |
|
Smith David V |
Executive Vice President & CFO |
|
2020-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
89,561 |
|
- |
|
Smith David V |
Executive Vice President & CFO |
|
2020-11-26 |
4 |
D |
$18.45 |
$127,674 |
D/D |
(6,920) |
67,561 |
|
- |
|
Lampert Mark N |
See Explanation of Responses |
|
2020-11-11 |
4 |
S |
$20.19 |
$149,247,137 |
D/D |
(7,393,340) |
81,263 |
|
-110% |
|
Smith David V |
Executive Vice President & CFO |
|
2020-11-11 |
4 |
D |
$18.00 |
$196,344 |
D/D |
(10,908) |
74,481 |
|
- |
|
Smith David V |
Executive Vice President & CFO |
|
2020-11-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
85,389 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2020-11-11 |
4 |
D |
$18.00 |
$198,018 |
D/D |
(11,001) |
116,010 |
|
- |
|
Sarena Francis Willard |
Chief Strategy Officer |
|
2020-11-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
127,011 |
|
- |
|
Ringo William R |
Director |
|
2020-11-11 |
4 |
AS |
$22.50 |
$1,776,578 |
D/D |
(78,959) |
10,000 |
|
110% |
|
Ringo William R |
Director |
|
2020-11-11 |
4 |
OE |
$2.22 |
$190,369 |
D/D |
78,959 |
36,000 |
|
- |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2020-11-11 |
4 |
D |
$18.00 |
$198,702 |
D/D |
(11,039) |
75,117 |
|
- |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2020-11-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
86,156 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2020-11-06 |
4 |
B |
$4.98 |
$149,520 |
D/D |
30,000 |
583,912 |
2.45 |
658% |
|
Lampert Mark N |
10% Owner |
|
2020-11-04 |
4 |
B |
$4.88 |
$2,034,572 |
D/D |
416,562 |
581,578 |
2.45 |
638% |
|
Lampert Mark N |
10% Owner |
|
2020-10-06 |
4 |
B |
$5.04 |
$1,738,288 |
D/D |
345,241 |
566,223 |
2.45 |
315% |
|
White David |
See Remarks |
|
2020-09-30 |
4 |
D |
$4.70 |
$32,505 |
D/D |
(6,916) |
36,039 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2020-09-22 |
4 |
B |
$3.80 |
$122 |
D/D |
32 |
541,116 |
2.37 |
379% |
|
Collins Helen Louise |
EVP and Chief Medical Officer |
|
2020-08-20 |
4 |
D |
$4.69 |
$3,879 |
D/D |
(827) |
64,156 |
|
- |
|
Bvf Ii Gp Llc |
|
|
2020-05-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,008,781 |
|
3% |
|
329 Records found
|
|
Page 2 of 14 |
|
|